Clinical Trial Update: Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update describes using ultrasound as an imaging biomarker to assess early response to tocilizumab in combination with methotrexate f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Actemra (tocilizumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Maria Stoenoiu | Conditions: Rheumatoid Arthritis | Phase 3 | Status: UNKNOWN